METHOD FOR DETERMINING THERAPEUTIC APPROACH TO POSTERIOR AGGRESSIVE RETINOPATHY OF PREMATURE INFANTS USING FLUORESCENT IRIDOANGIOGRAPHY Russian patent published in 2022 - IPC A61F9/08 A61B3/12 

FIELD: medicine; ophthalmology.

SUBSTANCE: invention can be used to determine the therapeutic approach to aggressive posterior retinopathy of prematurity (ROP). That is ensured by fluorescent iridoangiography (FIAG) and ultrasonic ophthalmic scanning in B-mode. When detecting, according to FIAG, vasodilatation and tortuosity of iris, absence of differentiation of border between ciliary and pupillary zones, contrasting along the pupillary edge of small newly formed vessels with fluorescein release in the late phase, the presence of newly formed vessels in the pupil in the form of a network of shunts, formation of additional shunt loops and their dilation, accompanied by prolonged contrasting, as well as retinal detachment, according to ophthalmic scanning in B-mode, the patient undergoes vitrectomy. If the FIAG shows all of the above signs and the absence of retinal detachment, according to ophthalmic scanning in B-mode, the patient undergoes intravitreal anti-VEGF therapy.

EFFECT: invention enables to determine the most effective method of treating a posterior aggressive ROP based on detecting vascular changes in the anterior segment of the eye according to the FIAG data, if retinoscopy is impossible.

1 cl, 3 dwg